Activation of guanosine 5′-[γ-35S]thio-triphosphate binding through M1 muscarinic receptors in transfected Chinese hamster ovary cell membranes:: 2.: Testing the "two-states" model of receptor activation

被引:13
作者
Waelbroeck, M [1 ]
机构
[1] Free Univ Brussels, Fac Med, Lab Chim Biol & Nutr, Sch Med,Dept Biochem & Nutr, B-1070 Brussels, Belgium
关键词
D O I
10.1124/mol.59.4.886
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
I suggested in the accompanying article [Mol Pharmacol 2001; 59:875-885] that muscarinic receptors catalyzed G protein activation. Acetylcholine or carbamylcholine recognition facilitated not only the GDP release from receptor-coupled inactive G proteins but also the release of G(GTP gammaS)* from the (unstable) HRG(GTP gammaS)* complex. The two effects facilitated [S-35]GTP gammaS binding in the presence of GDP, but could be studied separately by comparing [S-35]GTP gammaS binding in the absence and presence of GTP. Guanyl nucleotides affected the efficiency of receptor-G protein coupling. The relative efficacies of partial agonists in the absence and presence of GTP should remain nonlinearly correlated if all agonists stabilize (to different extents) the same active receptor conformation. The correlation between M-1 muscarinic agonists' efficacy in accelerating [S-35]GTP gammaS binding in the absence of other nucleotides and their in vivo efficacy (inositol phosphate accumulation) was in fact very poor. This probably reflected the presence of GTP in intact cells: pertussis toxin pretreatment (which inactivates the G(i/o) proteins) did not affect the agonists' efficacy profile (evaluated in the absence of spare receptors), but the addition of GTP to the [S-35]GTP gammaS binding medium did. These results did not support the allosteric "two states" model of receptor activation, but suggested that different agonists induced different receptor conformations ("induced fit").
引用
收藏
页码:886 / 893
页数:8
相关论文
共 41 条
[1]   Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus [J].
Berg, KA ;
Maayani, S ;
Goldfarb, J ;
Scaramellini, C ;
Leff, P ;
Clarke, WP .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :94-104
[2]   Differential opioid agonist regulation of the mouse mu opioid receptor [J].
Blake, AD ;
Bot, G ;
Freeman, JC ;
Reisine, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) :782-790
[3]  
Bonhaus DW, 1998, J PHARMACOL EXP THER, V287, P884
[4]   Cannabinoid receptor agonist efficacy for stimulating [35S]GTPγS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity [J].
Breivogel, CS ;
Selley, DE ;
Childers, SR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (27) :16865-16873
[6]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[7]  
CHIDIAC P, 1994, MOL PHARMACOL, V45, P490
[8]  
DeLapp NW, 1999, J PHARMACOL EXP THER, V289, P946
[9]  
DELEAN A, 1982, MOL PHARMACOL, V21, P5
[10]   Agonists induce conformational changes in transmembrane domains III and VI of the beta(2) adrenoceptor [J].
Gether, U ;
Lin, S ;
Ghanouni, P ;
Ballesteros, JA ;
Weinstein, H ;
Kobilka, BK .
EMBO JOURNAL, 1997, 16 (22) :6737-6747